Drug-patent reform seeks accessibility, less data
As prescription drugs remain inaccessible to most, the notion of patent reform is seemingly settling into public discourse.
As prescription drugs remain inaccessible to most, the notion of patent reform is seemingly settling into public discourse.
People afflicted with the deadly and crushing disease amyotrophic lateral sclerosis (ALS) are searching for some glimmer of hope in the shadow of promising drug treatments, however ALS patients do not currently have real access to these drugs, which are presently in trials.